Cargando…
Long-term survival after immunotherapy and targeted therapy without chemotherapy in an elderly patient with HER2-positive gastroesophageal junction cancer: A case report
A 74-yr-old man underwent thoracic laparoscopy combined with radical gastrectomy, and the postoperative pathological diagnosis was esophageal and gastric cardia cancer pT3N1M0, pStage IIB. Immunohistochemical staining for HER2 (3+) and PD-L1 (<5%) was positive. Adjuvant chemotherapy was not perfo...
Autores principales: | Li, Wei-Ling, Zhang, Ying, Zhang, Xiao-Ling, Du, Yun-Yi, Hu, Wen-Qing, Zhao, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746372/ https://www.ncbi.nlm.nih.gov/pubmed/36166751 http://dx.doi.org/10.1080/21645515.2022.2121109 |
Ejemplares similares
-
Immunotherapy of glioblastoma: Recent advances and future prospects
por: Yuan, Boyang, et al.
Publicado: (2022) -
The employment of vaccinia virus for colorectal cancer treatment: A review of preclinical and clinical studies
por: Ling, Qiaoyun, et al.
Publicado: (2022) -
PD-1 inhibitor treatment in a penile cancer patient with MMR/MSI status heterogeneity: A case report
por: Du, YunYi, et al.
Publicado: (2022) -
Ipilimumab and Cancer Immunotherapy: A New Hope for Advanced Stage Melanoma
por: Mansh, Matthew
Publicado: (2011) -
Monitoring of molecular profiling of allergen-antibody responses in HDM-immunotherapy patients
por: Nittner-Marszalska, Marita, et al.
Publicado: (2022)